Milestone Scientific (MLSS) Amortization of Deferred Charges (2021 - 2026)
Milestone Scientific (MLSS) posted Amortization of Deferred Charges of $28579.0 for Q1 2026, down 8.2% sequentially from $31133.0 in Q4 2025, and up 10.45% YoY from $25875.0 in Q1 2025.
Milestone Scientific (MLSS) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends
Milestone Scientific has reported Amortization of Deferred Charges for 6 years, with the latest figure at $28579.0 in Q1 2026.
- Quarterly Amortization of Deferred Charges rose 10.45% year-over-year to $28579.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $110167.0 (up 11.5% YoY) and the FY2025 annual result came in at $107463.0, up 10.34% from the prior year.
- Amortization of Deferred Charges retreated to $28579.0 in Q1 2026 per MLSS's latest filing, from $31133.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $31481.0 in Q2 2025 and troughed at $16207.0 in Q3 2022.
- A 5-year average of $23671.6 and a median of $23045.0 in 2023 frame the typical range for Amortization of Deferred Charges.
- The sharpest annual moves came in 2022 and 2025: Amortization of Deferred Charges surged 53.56% in 2022, then decreased 22.99% in 2025.
- Over 5 years, Amortization of Deferred Charges stood at $20835.0 in 2022, then decreased by 6.97% to $19383.0 in 2023, then surged by 30.24% to $25244.0 in 2024, then gained by 23.33% to $31133.0 in 2025, then slipped by 8.2% to $28579.0 in 2026.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $28579.0, $31133.0, and $18974.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Milestone Scientific | 41.18 Mn | 38.57 Mn | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28,579.00 |
| Mar 31, 2026 | 28,579.00 |
| Dec 31, 2025 | 31,133.00 |
| Dec 31, 2025 | 31,133.00 |
| Sep 30, 2025 | 18,974.00 |
| Sep 30, 2025 | 18,974.00 |
| Jun 30, 2025 | 31,481.00 |
| Jun 30, 2025 | 31,481.00 |
| Mar 31, 2025 | 25,875.00 |
| Mar 31, 2025 | 25,875.00 |
| Dec 31, 2024 | 25,244.00 |
| Dec 31, 2024 | 25,244.00 |
| Sep 30, 2024 | 24,638.00 |
| Sep 30, 2024 | 24,638.00 |
| Jun 30, 2024 | 23,045.00 |
| Jun 30, 2024 | 23,045.00 |
| Mar 31, 2024 | 24,466.00 |
| Mar 31, 2024 | 24,466.00 |
| Dec 31, 2023 | 19,383.00 |
| Dec 31, 2023 | 19,383.00 |